China plans comprehensive reform of drug regulations

02/27/2013 | Regulatory Focus

China's State Food and Drug Administration has announced plans for wide-ranging changes in its drug regulatory process. The plan will foster research and development through a more favorable regulatory environment; update the national strategy for generic drugs; boost the quality of pharmaceutical clinical trials and how they are managed; and encourage the creation of more pediatric pharmaceuticals.

View Full Article in:

Regulatory Focus

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA